Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a1edc6e769881395769abbcc654796f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f736ff7531bb706c091c33174454dcab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_474b706001bac58231905c0dead97311 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eadec46c3f6ebebbed42a27c48217ff1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90c4d61b05b3ccbd0342338cc4ae20a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e7b01137b999b1c4147af4817c04241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-33 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-333 |
filingDate |
2012-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_309658f751ac07aba54c9d93c7a2a407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0845fd8a6b369b21f572fc7497f1f0ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ceae01a4d604aefbe6eb240acaab192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48417187f40796c40bf5410e2b52c6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f188247da3d6fa04b4f3d0c2b7a666 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_454d1bd64ba4894908be724ffd00fe06 |
publicationDate |
2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10017470-B2 |
titleOfInvention |
Treatment for lipodystrophy |
abstract |
The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (Pis) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient. |
priorityDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |